Zusammenfassung
Anliegen Es soll eine Übersicht über Diagnostik, Verlauf und Therapie der „nichtschizophrenen psychotischen Störungen” gegeben werden. Methode Mithilfe von „Medline” und „Cochrane Database of Systematic Reviews” wurde eine Literatursuche durchgeführt. Ergebnisse Obwohl die „nichtschizophrenen psychotischen Störungen” im klinischen Alltag keine Rarität darstellen, gibt es hier bisher kaum evidenzbasierte Behandlungsempfehlungen. Schlussfolgerungen Es sind umfangreiche Therapiestudien für diese Patientengruppe oder die Etablierung von alternativen diagnostischen Ansätzen zu fordern.
Abstract
Objective To provide an overview of diagnostics, outcome and treatment of „non-schizophrenic psychotic disorders” (ICD-10: delusional disorders, acute and transient psychotic disorders and schizoaffective disorders). Methods Literature was identified by searches in „Medline” and „Cochrane Database of Systematic Reviews”. Results The frequency of „non-schizophrenic psychotic disorders” within the whole diagnostic group „schizophrenia, schizotypal and delusional disorders” (ICD-10) ranges between 22 % and 49 %. Patients with these disorders show a more favourable long-term outcome than those with schizophrenia. With regard to therapy, as yet only a small empirical database exists. The comparability of those studies is limited by the use of different diagnostic criteria. There are only few evidence-based treatment guidelines for these disorders. Conclusions There is a substantial need for controlled studies on the treatment of „non-psychotic schizophrenic disorders”. Alternatively, clinical guidelines could be based on a dichotomy of affective and schizophrenic disorders or on a dimensional approach.
Schlüsselwörter
evidenzbasierte Medizin - Review - Diagnosen - Behandlung
Key words
evidence-based medicine - review - diagnoses - treatment
Literatur
-
1 American Psychiatric Association .Diagnostisches und statistisches Manual psychischer Störungen DSM-IV. Dt. Bearbeitung und Einführung von H Saß, HU Wittchen u. M Zaudig. Göttingen; Hofgrefe 1996
-
2 American Psychiatric Association .Practice guideline for the treatment of patients with schizophrenia 2th edition. Washington DC; American Psychiatric Association 2004
-
3 Basan A, Leucht S. Valproate for schizophrenia. The Cochrane Database of Systematic Reviews, Issue 3. Chichester, UK; J. Wiley & Sons 2003
-
4
Baethge C.
Long-term treatment of schizoaffective disorder. Review and recommendations.
Pharmacopsychiatry.
2003;
36
45-56
-
5
Baethge C, Gruschka P, Berghöfer A. et al .
Prophylaxis of schizoaffective disorder with lithium or carbamazepin: outcome after long-term follow-up.
J Affect Disord.
2004;
79
43-50
-
6
Benabarre A, Vieta E, Colom F. et al .
Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences.
Eur Psychiatry.
2000;
16
167-172
-
7
del Rigo Vega J M, Ayuso-Gutierrez J L.
Course of schizoaffective psychosis. A retrospective study.
Acta Psychiatr Scand.
1990;
81
534-537
-
8 Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) .Behandlungsleitlinie Schizophrenie. Darmstadt; Steinkopff 2006
-
9
Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz W F, Möller H J.
World federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.
World J Biol Psychiatry.
2005;
6
132-191
-
10
Grossman L S, Harrow M, Goldberg J F, Fichtner C G.
Outcome of schizoaffective disorder at two long-term follow-ups: Comparison with outcome of schizophrenia and affective disorders.
Am J Psychiatry.
1991;
148
1359-1365
-
11
Harrow M, Grossman L S, Herbener E S, Davies W E.
Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms.
Br J Psychiatry.
2000;
177
421-426
-
12
Healy D, Savage M, Michael P. et al .
Psychiatric bed utilization: 1896 and 1996 compared.
Psychol Med.
2001;
31
779-790
-
13
Himmelhoch J M, Fuchs C Z, May S J, Symons J, Neil J F.
When a schizoaffective diagnosis has meaning.
J Nerv Ment Dis.
1981;
169
277-282
-
14
Hoche A.
Die Bedeutung der Symptomenkomplexe in der Psychiatrie.
Z ges Neurol Psychiatr.
1912;
12
540-551
-
15
Jablensky A.
Classification of nonschizophrenic psychotic disorders: a historical perspective.
Curr Psychiatry Rep.
2001;
3
326-331
-
16
Jäger M, Bottlender R, Strauss A, Möller H J.
On the descriptive validity of ICD-10 schizophrenia: Empirical analyses in the spectrum of non-affective functional psychoses.
Psychopathology.
2003;
36
152-159
-
17
Jäger M, Hintermayr M, Bottlender R, Strauss A, Möller H J.
Course and outcome of first-admitted patients with acute and transient psychotic disorders (ICD-10 F23): focus on relapses and social adjustment.
Eur Arch Psychiatry Clin Neurosc.
2003;
253
209-215
-
18
Jäger M, Bottlender R, Strauss A, Möller H J.
Klassifikation der funktionellen Psychosen. Die Bedeutung der ICD-10-Diagnosen (Forschungskriterien) für die Vorhersage des Langzeitverlaufes.
Fortschr Neurol Psychiat.
2004;
72
70-78
-
19
Jäger M, Bottlender R, Strauss A, Möller H J.
Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders.
Acta Psychiatr Scand.
2004;
109
30-37
-
20
Jäger M, Bottlender R, Strauss A, Möller H J.
Die nosologische Stellung der schizoaffektiven Störungen (ICD-10: F25). Symptomatik und Verlauf.
Schweizer Arch Neurol Psychiatr.
2004;
155
204-211
-
21
Jäger M, Bottlender R, Strauss A, Möller H J.
Classification of functional psychoses and its implication for prognosis. Comparison between ICD-10 and DSM-IV.
Psychopathology.
2004;
37
110-117
-
22
Jorgensen P.
Course and outcome in delusional disorders.
Psychopathology.
1994;
27
79-88
-
23
Jorgensen P, Bennedsen B, Christensen J, Hyllested A.
Acute and transient psychotic disorder: a 1-year follow-up study.
Acta Psychiatr Scand.
1997;
96
150-154
-
24 Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 6. Aufl. Leipzig; Barth 1899
-
25
Lange W, Munk-Jorgensen P, Bertelsen A, Schurmann A, Michels R, Malchow C P, Dilling H.
Comparison of psychiatric ICD-10 diagnoses in Denmark and Germany.
Psychopathology.
2002;
35
36-47
-
26 Leucht S, McGrath J, White P, Kissling W. Carbamazepin for schizophrenia and schizoaffective psychoses. The Cochrane Database of Systematic Reviews, Issue 3. Chichester, UK; John Wiley & Sons, Ltd 2002
-
27 Leucht S, McGrath J, Kissling W. Lithium for schizophrenia. The Cochrane Database for Systematic Reviews, Issue 3. Chichester, UK; John Wiley & Sons, Ltd 2003
-
28
Levinson D F, Umapathy C, Musthaq M.
Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
Am J Psychiatry.
1999;
156
1138-1148
-
29
Marneros A, Deister A, Rhode A.
Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course.
Acta Psychiatr Scand.
1990;
82
352-358
-
30 Marneros A. Behandlung schizoaffektiver Psychosen. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Stuttgart; Thieme 2000
-
31
Marneros A, Pillmann F, Haring A. et al .
What is schizophrenic in acute and transient psychotic disorder?.
Schizophr Bull.
2003;
29
311-323
-
32
Marneros A, Pillmann F, Haring A, Balzuweit S, Blöink R.
Features of acute and transient psychotic disorders.
Eur Arch Psychiatry Clin Neurosci.
2003;
253
167-174
-
33
McElroy S L, Keck P E, Strakowski S M.
An overview of the treatment of schizoaffective disorder.
J Clin Psychiatry.
1999;
60 (Suppl 5)
16-21
-
34
Menuk M, Legault S, Schmidt P, Remington G.
The nosological status of the remitting atypical psychoses.
Compr Psychiatry.
1989;
30
53-73
-
35
Möller H J, Hohe-Schramm M, Cording-Tömmel C. et al .
The classification of functional psychoses and its implications for prognosis.
Br J Psychiatry.
1989;
154
467-472
-
36 Möller H J, Deister A. Schizophrenieähnliche Störungen und nichtorganische Wahnerkrankungen. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. Berlin; Springer 2002: 1123-1149
-
37 National Institute for Clinical Excellence .Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. London; NICE 2002
-
38
Opjordsmoen S.
Delusional disorders. I. Comparative long-term outcome.
Acta Psychiatr Scand.
1989;
80
603-612
-
39
Pope H G, Lipinski J F, Cohen B M, Axelrod D T.
„Schizoaffective Disorder”: An invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia and affective disorder.
Am J Psychiatry.
1980;
137
921-927
-
40
Royal Australian and New Zealand College of Psychiatrists .
Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.
Aust N Z J Psychiatry.
2005;
39
1-30
-
41 Rupprecht R, Hampel H. Psychiatrie und Psychotherapie. Ihr roter Faden durchs Studium nach der ÄAppo. Stuttgart; Wissenschaftliche Verlagsgesellschaft 2006
-
42
Sajith S G, Chandrasekaran R, Sadanandan-Unni K E, Sahai A.
Acute polymorphic psychotic disorder: diagnostic stability over 3 years.
Acta Psychiatr Scand.
2002;
105
104-109
-
43 Schneider K. Klinische Psychopathologie. 13. Auflage. Stuttgart; Thieme 1987
-
44
Silva H, Jerez S, Ramirez A, Renteria P, Aravena N, Salazar D, Labarca R.
Effects of pimozid on the psychopathology of delusional disorder.
Prog Neuropsychopharmacol Biol Psych.
1998;
22
331-340
-
45
Singh S P, Burns T, Amin S, Jones P B, Harrison G.
Acute and transient psychotic disorders: precursors, epidemiology, course and outcome.
Br J Psychiatry.
2004;
185
452-459
-
46
Smith D A, Buckley P F.
Pharmacotherapy of delusional disorders in the context of offending and the potential for compilsory treatment.
Behav Sci Law.
2006;
24
351-367
-
47
Stephens J, Pascal R, Mc Hugh P R.
Long-term follow-up of patients with a diagnosis of paranoid state and hospitalized, 1913 to 1940.
J Nerv Ment Dis.
2000;
188
202-208
-
48 Sultana A, McMonagle T. Pimozid for schizophrenia or related psychoses. The Cochrane Database of Systematic Reviews 2000
3
-
49
Tsuang D, Coryell W.
An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder and schizophrenia.
Am J Psychiatry.
1993;
150
1182-1188
-
50
van Os J, Gilvarry C, Bale R. et al., on behalf of the UK700 Group .
A comparison of the utility of dimensional and categorial representations of psychosis.
Psychol Med.
1999;
29
595-606
-
51
Vollmer-Larsen A, Jacobsen T B, Hemmingsen R, Parnas J.
Schizoaffective disorder - the reliability of its clinical diagnostic use.
Acta Psychiatr Scand.
2006;
113
402-407
-
52
Welner A, Croughan J L, Fishman R, Robins E.
The group of schizoaffective and related psychoses - critique, record, follow-up and family studies: a follow-up study.
Compr Psychiatry.
1977;
18
413-422
-
53 World Health Organisation .Internationale Klassifikation psychischer Störungen, ICD-10, Kapitel V (F); Klinisch-diagnostische Leitlinien. Bern; Huber 1999
Dr. Markus Jäger
Klinik für Psychiatrie II der Universität Ulm, Bezirkskrankenhaus Günzburg
Ludwig-Heilmeyer-Straße 2
89312 Günzburg
Email: Markus.Jaeger@bkh-guenzburg.de
